ATTANA AB
Desconocido
NanoCarb: Glyco Nanoparticles for Applications in Advance Nanomedicine
ATTANA AB
participó en un
H2020:
H2020-MSCA-ITN-2018
The advance of nanomedicine requires the development of novel materials with tailored properties, controlled circulation, optimal targeting...
2018-08-20 - 2023-03-31 | Financiado
2018-08-20 - 2023-03-31 | Financiado
NANOMILE: Engineered nanomaterial mechanisms of interactions with living systems and the environment a univer...
ATTANA AB
participó en un
FP7:
The NanoMILE project is conceived and led by an international elite of scientists from the EU and US with the aim to establish a fundamental...
Financiado
Financiado
DYNANO: DYNAMIC INTERACTIVE NANOSYSTEMS
ATTANA AB
participó en un
FP7:
The key and direct objective of DYNANO is to provide training with a deep knowledge and expertise on Dynamic Interactive Nanosystems for bio...
Financiado
Financiado
WntsApp: WNT mediated signal relay in stem cells and oncogenesis from basic biology to applications
ATTANA AB
participó en un
FP7:
The ITN WntsApp is organized to achieve 3 key aims: (i) Provide a committed training programme for young researchers to bridge the gap betwe...
Financiado
Financiado
NanoClassifier: NanoClassifier QCM for rapid label free Bionano interface evaluation and screening of effectivenes...
ATTANA AB
participó en un
FP7:
Nanomedicine and Nanosafety rely on the same fundamental interactions between the nanoparticle interface and the biological milieu surroundi...
Financiado
Financiado
* No se disponen de datos de la empresa actual.